tiprankstipranks
pc:revyv

Revyve

Food & Beverage
Revyve is a Dutch food-tech company specializing in the development of sustainable yeast proteins designed to replace eggs and additives in mainstream food categories. By offering natural, price-competitive, and environmentally friendly alternatives, Revyve addresses key industry challenges such as rising egg costs, the demand for clean-label products, and sustainability goals. The company leverages its proprietary technology to produce functional ingredients that mimic the performance of eggs, enhancing the texture and sensory experience of foods across various categories, including bakery, sauces, alternative meat, and plant-based dairy.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$24M
Total Amount Raised$24M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$24M
Latest Funding Amount$24M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 23, 2025
Series B
$24.00M
―

Investors

Investor Name
Funding Round
Invest-NL
Series B
ABN AMRO Sustainable Impact Fund
Series B
Brabantse Ontwikkelings Maatschappij
Series B
Lallemand Bio-Ingredients
Series B
Danstar Ferment
Series B
Grey Silo Ventures
Series B
Oost NL
Series B
Royal Cosun
Series B

Related News and Analysis

Talkiatry Partners With AMGA to Scale In-Network Psychiatric Access Nationwide

Talkiatry Partners With AMGA to Scale In-Network Psychiatric Access Nationwide

New updates have been reported about Talkiatry. Talkiatry has entered a strategic partnership with AMGA to expand in-network...
6m ago
TALKI
Fibr AI Unveils Ads and LLM Personalization Tools to Lift Conversion and Cut Acquisition Costs

Fibr AI Unveils Ads and LLM Personalization Tools to Lift Conversion and Cut Acquisition Costs

New updates have been reported about Fibr AI. Fibr AI has introduced two web personalization capabilities aimed at...
6m ago
FIBRA
TransPerfect Expands Media Footprint With Acquisition of Italy’s Studio Emme

TransPerfect Expands Media Footprint With Acquisition of Italy’s Studio Emme

New updates have been reported about TransPerfect. TransPerfect has acquired Rome-based Studio Emme SpA, a long-established dubbing and...
7m ago
TRA2H
Lettuce Financial to Acquire Carry, Adding $225 Million Retirement Platform for Solopreneurs

Lettuce Financial to Acquire Carry, Adding $225 Million Retirement Platform for Solopreneurs

New updates have been reported about Lettuce Financial. Lettuce Financial plans to acquire Carry’s retirement and investing platform,...
7m ago
LETTU
BQP Backs Quantum Hubs Legislation to Deepen Role in New York’s Growing Quantum Ecosystem

BQP Backs Quantum Hubs Legislation to Deepen Role in New York’s Growing Quantum Ecosystem

New updates have been reported about BQP. BQP is positioning itself at the center of New York’s quantum...
7m ago
BQPXX
Cala Health Secures FDA Clearance for Next-Gen Wearable Tremor Device Cala kIQ Plus

Cala Health Secures FDA Clearance for Next-Gen Wearable Tremor Device Cala kIQ Plus

New updates have been reported about Cala Health. Cala Health has received U.S. Food and Drug Administration clearance...
7m ago
CALAH
Verismo to Unveil First-in-Human KIR-CAR Data for SynKIR-110 and SynKIR-310 at AACR 2026

Verismo to Unveil First-in-Human KIR-CAR Data for SynKIR-110 and SynKIR-310 at AACR 2026

New updates have been reported about Verismo Therapeutics. Verismo Therapeutics will showcase pivotal first-in-human and preclinical data for...
18m ago
VER0L
Verismo Therapeutics Secures $28 Million to Advance KIR-CAR Trials Ahead of Key 2026 Data Readout

Verismo Therapeutics Secures $28 Million to Advance KIR-CAR Trials Ahead of Key 2026 Data Readout

New updates have been reported about Verismo Therapeutics. Verismo Therapeutics has obtained a $28 million capital infusion from...
18m ago
VER0L
Sonire Therapeutics Raises $18 Million to Drive Breakthrough HIFU Pancreatic Cancer Program and U.S. Expansion

Sonire Therapeutics Raises $18 Million to Drive Breakthrough HIFU Pancreatic Cancer Program and U.S. Expansion

New updates have been reported about Sonire Therapeutics. Sonire Therapeutics has secured $18 million in Series A funding...
18m ago
SONIR
Gallant Advances Feline OA Stem Cell Program With Positive Data and FDA Fast-Track Pathway

Gallant Advances Feline OA Stem Cell Program With Positive Data and FDA Fast-Track Pathway

New updates have been reported about Gallant. Gallant has reported positive pilot data for its intravenous uterine-derived mesenchymal...
30m ago
GAL3M